DARE vs DCOY

Dare Bioscience, Inc. vs Decoy Therapeutics Inc. — Valuation Comparison 2026

DARE

Biotechnology
Dare Bioscience, Inc.
Quality
4.4
out of 10
Value Trap
30
LOW
Price
$2.28
Last close
Models
9/13
Active
VS

DCOY

Biotechnology
Decoy Therapeutics Inc.
Quality
3.7
out of 10
Value Trap
39
LOW
Price
$7.91
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType DARE Fair ValueDARE Upside DCOY Fair ValueDCOY Upside
Bayesian DCF Intrinsic $1.22 -46.5% $10.17 +28.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.93 -59.4% $0.72 -87.8%
Dynamic NAV Asset-Based $2.81 +23.3% $20.47 +158.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for DARE vs DCOY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DARE vs DCOY — Which Stock Is More Undervalued?

DARE scores higher with a 4.4/10 quality rating vs DCOY's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Dare Bioscience, Inc. (DARE) and Decoy Therapeutics Inc. (DCOY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DARE currently trades at $2.28 with a QOC of 4.4/10, while DCOY trades at $7.91 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).